Safety and tolerability of sitagliptin in clinical studies: a pooled analysis of data from 10,246 patients with type 2 diabetes

Safety and tolerability of sitagliptin in clinical studies: a pooled analysis of data from 10,246 patients with type 2 diabetes

<p>Abstract</p> <p>Background</p> <p>In a previous pooled analysis of 12 double-blind clinical studies that included data on 6,139 patients with type 2 diabetes, treatment with sitagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor, was shown to be generally well toler...

Full description

Bibliographic Details
Main Authors: Guo Hua, Golm Gregory T, Johnson Jeremy, Round Elizabeth, Engel Samuel S, Williams-Herman Debora, Musser Bret J, Davies Michael J, Kaufman Keith D, Goldstein Barry J
Format: Article
Language:English
Published: BMC 2010-04-01
Series:BMC Endocrine Disorders
Online Access:http://www.biomedcentral.com/1472-6823/10/7

Internet

http://www.biomedcentral.com/1472-6823/10/7

Similar Items